A 20-year-old womanwho had suffered from Still's disease was admitted for fever and progressive pneumonitis after long-term remission. High spiking fever, leukocytosis, splenomegaly and an extremely high serum ferritin concentration strongly suggested a relapse of Still's disease. Intensive therapy with high-dose methylprednisolone, cyclophosphamide and gammaglobulin was required for the severe pneumonitis, which was thought to be a rare manifestation in Still's disease. (Internal Medicine 32: 902-905, 1993) 
Introduction
Pneumonitis, an important manifestation in manysystemic rheumatic disorders , greatly influences respiratory function and prognosis.
Progressive systemic sclerosis, polymyositis/ dermatomyositis, mixed connective tissue disease and rheumatoid arthritis are frequently associated with pneumonitis. In contrast, most of the pulmonarymanifestations observed in juvenile onset Still' s disease (JOSD) or adult onset Still's disease (AOSD)are pleuritis and pleural effusion. Only a few reports have described severe pneumonitis in JOSD/AOSD (1) (2) (3) . Wedescribe a patient with JOSDexacerbated after prolonged remission in whomrapidly progressive pneumonitis was a prominent feature.
Case Report
The patient was a 20-year-old Japanese woman.She had suffered fromjuvenile rheumatoid arthritis (JRA) since 1 974 (3 y.o.), and during the course had had recurrent spiking fever, typical rheumatoid rash, polyarthralgias, lymphadenopathy, hepatosplenomegaly and pericarditis. On the flare-up at age 1 3, her symptoms were resistant to steroid; intravenous gamma globulin was given with favorable progress as described previously (4). All symptoms disappeared in 1986 (15 y.o.), and she had remained asymptomatic for 5 years without any medication. However, she became febrile in the beginning of May 1991. Since the antibiotics and diclofenac prescribed by her physician were not effective and daily temperatures of up to 39.5°C accompanied sore throat and progressive dyspnea, she was admitted to our hospital on July 6. On the day of admission her temperature was 38.2°C in the morning and increased to 39.9°C in the afternoon. Respiration was shallow and rapid, and fine crackles were audible in the lower half of both lung fields. The tonsils were swollen and several cervical lymph nodes ranging from 5 to 10 mmin diameter were palpable. These were discrete and movable. On the left forefinger, an erythematous macule of 10 mmin diameter was observed. There was no finding of arthritis. The erythrocyte sedimentation rate was 118 mm/h. Hematological examination showedhypochromic microcytic anemia with a hemoglobin level of 9.2 g/dl, hematocrit of 26.4% and red blood cell count of 336xlO4/jil-Thrombocytopenia with a platelet count of 29,000/jjI and remarkable leukocytosis with a white blood cell count of 24,200/jxl were noted. Serological tests showed elevation of CRP and CH50, while anti-nuclear antibody or rheumatoid factor was not detected. Blood chemistry tests revealed hypoalbuminemia of 2.2 g/dl, glutamic oxaloacetic transaminase of 282 U/l, glutamic pyruvic transaminase of 69 U/l and lactic dehydrogenase (LDH) of 4,959 U/l. Analysis of the LDHisozyme showed predominance of the LDH2and LDH3fractions, compatible with pulmonary damage. Creatinine kinase was in the normal range (57 U/l). In addition, the serum ferritin concentration was 23,000 ng/ml, three hundred times the normal upper limit.
While detailed respiratory function could not be examined because of her poor condition, arterial blood gas analysis under supplementary oxygen at a rate of 2 1/min through nasal prongs showed PaO2 67 torr and PaCO2 35.7 torr. Repeated bacteriological examinations showed no growth of organisms in cultures of blood, urine or sputum. Serum IgM antibody to cytomegalovirus wasnot detectable and antibodies to other organismswerenot elevated. Chest roentgenogram showed elevation of the diaphragm and reticular shadows in both lungs that were prominent in the lower lung fields (Fig. 1) . CT scan of the thorax disclosed diffuse reticular shadows throughout both lungs, and honeycombing was visible in the subpleural area of the right lung (Fig.  2) . No pericardial effusion was observed on CT scan or echocardiography.
Abdominal ultrasound imaging revealed (Fig. 3) . Taken together, the high spiking fever with afternoon exacerbation, lymph node swelling, splenomegaly, negative findings suggestive of infection, markedelevation of the serum ferritin concentration and radiological findings yielded a diagnosis of relapsed JOSD associated with interstitial pneumonitis. For the progressive respiratory failure, intensive therapy with 1 ,000 mg/day of methylprednisolone was started from the first hospital day, and continued for 5 days. On day 4, reticular shadowson the chest roentgenogramwere increased and PaO2 was 63 torr under 3 1/min of oxygen supply. Based on these findings, the high-dose methylprednisolone was continued, supplemented with 1 ,000 mg of intravenous cyclophosphamide on day 4, and 5,000 mg of intravenous gammaglobulin from day 4 to 6 (Fig. 4) . From the second hospital week, the findings on chest roentgenograms gradually improved, and by day 20 oxygen inhalation was no longer needed. Respiratory function tests on the 65th hospital day showed PaO2 91 torr, PaCO2 43 torr, %VC49.5 and %DLC025.1. Since her spiking fever persisted in spite of the oral administration ofprednisolone, she was given a second gammaglobulin therapy on days 55 to 58, and nonsteroidal antiinflammatory drugs (NSAIDs) from day 67.
Discussion
JRA is a distinct clinical entity which apparently differs from adult rheumatoid arthritis in several of its characteristics (5, 6) . The American College of Rheumatology criteria for the diagnosis ofJRA divide it into three subsets depending on the mode of onset (7). The term "Still's disease" refers to the subset characterized by prominent systemic manifestations. Since Bywaters (8) described adult patients developing a disease indistinguishable from juvenile onset Still ' s disease, the entity "adult onset Still's disease" has been widely adopted for patients whodevelop the disease at age 16 someconfusion in nomenclature. Another term, "adult Still's disease," can be used to describe both AOSDand JOSDwhich has relapsed in adulthood. Although it is still controversial, both JOSD and AOSDshare commonphysical and laboratory features (9), and they may be essentially the same disorder. The patient described here had repeatedly experienced recurrences of spiking fever of unknownorigin, typical rheumatoid rash, polyarthralgias, lymphadenopathy, hepatosplenomegaly and pericarditis until the age of 15 years. She did well without any medication over the subsequent 5 years, but became febrile at 20 years of age. In a review of the long-term history of 21 AOSDpatients by Cush et al (10), 4 had had a history of an unexplained acute febrile illness during childhood which may have been an episode ofJOSD. Another patient had 8 distinct episodes of systemic involvement with 2 disease-free intervals of 10 years. Thus JOSD/AOSD can relapse even after long-term disease-free intervals.
Although roentgenogram showed bilateral ankylosis of intercarpal joints that is one of the characteristic features of JOSD/AOSD, she did not show clinical signs of arthritis during the current exacerbation. This is not necessarily unique because the number of joints with active arthritis tends to diminish in the long-term course of AOSD (8) . Wedo not know the clinical significance of the erythematous macule observed on admission. The rash was an erythematous, non-itchy macule of 10 mmin diameter on the left forefinger, which was different from the typical JRA rash. However, in spite of the lack of arthritis or typical rash, the fever (^39°C), negative anti-nuclear antibodies, negative rheumatoid factor, leukocytosis and splenomegaly were compatible with the criteria for AOSDby Cush et al (10) . Moreover, she showed a remarkably elevated serum ferritin concentration of 23,000 ng/ml (normal range, 4-70 ng/ml). Ohta et al (1 1) observed hyperferritinemia in 28 of 34 cases with AOSD,22 of which had levels 5 times the normal upper limit or higher. Hyperferritinemia is reported to be commonin children with JOSD as well (12) . Ferritin is one of the proteins produced in acute phase inflammatory response, but patients with rheumatic diseases other than JOSD/AOSD seldom have a serum ferritin level over 4,000 ng/ml (13) . This supports our diagnosis of a relapse of JOSD. The most notable finding in the present case was rapidly progressive respiratory failure. JOSD/AOSD occasionally have respiratory manifestations, but pleuritis and pleural effusions are morecommonthan pneumonitis. Among21 cases ofAOSD reported by Cush et al (10), 9 had pleuritis while pneumonitis was seen in 2 cases. Pneumonitis seems to be less frequent in JOSD.There have been only a few reports ofJOSD/AOSD with the severe pulmonarymanifestations observed in our case (1-3). Corbett et al (1) described a case of AOSDwith severe restrictive pulmonary defect in which the vital capacity was 26.5% of the predicted value, and transbronchial lung biopsy revealed patchy interstitial fibrosis and inflammation. PaO2 decreased only after exertion. The present case had severe respiratory dysfunction with hypoxemia, and intensive therapy with high-dose methylprednisolone, cyclophosphamide and gammaglobulin was needed.
Silverman et al (14) performed a pilot study on the effect of intravenous gammaglobulin in JOSD resistant to NSAIDs, antirheumatic drugs or steroids. They observed significant improvement in arthritis in 5 of 8 patients, and extraarticular features in 7 of 8 patients. The present patient also has a history of gammaglobulin therapy which successfully induced longterm remission (4). Although we should be cautious to apply this therapy to JOSD/AOSDbecause of the lack of controlled data to confirm the effectiveness, potential anaphylactic reactions and high cost, the present case was given high-dose gammaglobulin 2 times during the current flare-up for the life threatening severe pneumonitis unresponsive to high-dose steroid. Gammaglobulin treatments were followed by improvement of pneumonitis and pyrexia, however, combination with steroid and cyclophosphamide madeit difficult to evaluate the effect of each therapy precisely. Furthermore, after the second gamma globulin therapy, NSAIDs might contribute to the alleviation of the sustained fever. Even under the treatment with steroid and gammaglobulin, combination with NSAIDsmay exert an additional effect because the mechanismsof antiinflammatory actions are not the same amongthese treatments. Thrombocytopenia seems to be a very rare finding in JOSD/ AOSD,which usually show leukocytosis and thrombocytosis.
In the literature, one patient with AOSDwho had remarkable leukocytosis associated with thrombocytopenia and hemolytic anemia is described, but the details are not included (15) . Two other cases of cytopenia with JOSD/AOSD are reported: one was ajuvenile case with a WBCof 2,600/jllI and platelet count of 1 17,000/jil; the other was an adult case with aWBCof3,200/ jllI and platelet count of 51,700/nl (16). They do not seem to have been given medication before the cytopenia was noticed. The cause of the cytopenia was not clear. Because the latter case responded to splenectomy, the authors considered that hypersplenism caused the cytopenia in that case. Immune mechanisms responsible for the cytopenia in JOSD/AOSD have not been proposed to date. In the present patient, thrombocytopenia had not been noticed until she suffered from pneumonitis, and the effect of antibiotics and an antiinflammatory drug, given by her physician, on thrombocytopenia cannot be excluded, however, it should be noted that leukopenia and thrombocytopeniacan be encountered in the course of
